<DOC>
	<DOCNO>NCT00258609</DOCNO>
	<brief_summary>The purpose study determine whether 120 Unit , 240 unit botulinum toxin A effective treatment migraine without aura prophylaxis .</brief_summary>
	<brief_title>Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study</brief_title>
	<detailed_description>This 12-week , prospective double-blinded , randomize , multicenter study placebo , 120 Unit , 240 unit botulinum toxin A ( Dysport ® ) injection patient diagnosis Migraine without aura accord International Headache Society criterion . It design evaluate efficacy , safety , tolerability optimum dose Botulinum toxin type A ( Dysport ® ) injection migraine without aura prophylaxis .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Migraine without Aura</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>• The patient must give write ( personally sign date ) inform consent complete studyrelated procedure , mean assessment evaluation would form part normal medical care patient.• Able give write inform consent copy one.• Male female patient age 18 – 65.• Patients fulfil International Headache Society diagnostic criterion migraine• Patients experience average 2 8 migraine attack per month 3 month record 2 8 migraine attack screen period . • Patients prophylactic treatment migraine unchanged 3 month . • Able continuation anti – migraine drugs.• Female patient good general health potentially fertile sexually active must instruct investigator avoid pregnancy study condom contraceptive measure negative urine pregnancy test . ( possible visit control urine pregnancy test perform ) .• Patients judge reliable medication compliance record effect medication , well clearly motivate obtain benefit treatment . • The normal physical neurological examination whole study period . • Normal result haematology test • Liver transaminase inferior 2 upper normal value laboratory . • Patients fulfil international Headache Society criterion diagnostic pure migraine aura.• The patient pregnant lactating.• The patient female risk pregnancy study , take adequate precaution pregnancy.• The patient know hypersensitivity test material relate compounds.• The patient unable unwilling comply fully protocol.• The patient receive unlicensed drug within previous 6 months.• Treatment investigational drug ( ) within 6 month screen visit.• The patient previously enter study.• Patient past history predominant tension type headache , botulism , neuromuscular disorder ( e.g . myasthenia gravis , Lambert – Elton Syndrome ) • Patient significant medical / neurological / psychiatric disorder blood dyscrasia , thrombocytopenia , rheumatoid arthritis , congestive heart failure , coronary artery heart diseases , dementia , psychosis , major depression condition could influence clinical trial . • History drug abuse ( narcotic ( ) , cafergot , others ) drug ( botulinum toxin type A ) allergy.• Treatment BTX A within 6 month Treatment medical condition may put participant risk exposure BTXA ( neuromuscular disorder , aminoglycoside antibiotic , curarelike agent ) .• History migrainous infarction , hemiplegic migraine.• Unable fill patient diary home migraine attack.• Patient plan schedule elective surgery study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2005</verification_date>
	<keyword>Botulinum toxin type A ,</keyword>
	<keyword>Dysport® , Dysport</keyword>
	<keyword>Migraine without aura ,</keyword>
	<keyword>Migraine prophylaxis .</keyword>
</DOC>